CELLDEX THERAPEUTICS INC
NASDAQ: CLDX (Celldex Therapeutics, Inc.)
Kemas kini terakhir: 22 jam lalu35.28
-0.14 (-0.40%)
| Penutupan Terdahulu | 35.42 |
| Buka | 35.76 |
| Jumlah Dagangan | 499,876 |
| Purata Dagangan (3B) | 975,375 |
| Modal Pasaran | 2,769,200,128 |
| Harga / Jualan (P/S) | 2.72 |
| Harga / Buku (P/B) | 6.09 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Aug 2026 |
| Margin Operasi (TTM) | -9,027.19% |
| EPS Cair (TTM) | -2.70 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 345.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.49% |
| Nisbah Semasa (MRQ) | 21.67 |
| Aliran Tunai Operasi (OCF TTM) | -171.51 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -101.09 M |
| Pulangan Atas Aset (ROA TTM) | -16.88% |
| Pulangan Atas Ekuiti (ROE TTM) | -23.20% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Celldex Therapeutics, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 1.0 |
| Osilator Teknikal | 2.5 |
| Purata | 0.00 |
|
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 0.32% |
| % Dimiliki oleh Institusi | 113.13% |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |